Navamedic ASA (OSL:NAVA)

Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 532.39 million. The enterprise value is 600.99 million.

Market Cap	532.39M
Enterprise Value	600.99M

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 23.98 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	23.98M
Shares Outstanding	23.98M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.09%
Owned by Institutions (%)	52.70%
Float	21.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	28.01
PS Ratio	1.02
PB Ratio	2.46
P/TBV Ratio	n/a
P/FCF Ratio	13.31
P/OCF Ratio	12.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.19, with an EV/FCF ratio of 15.03.

EV / Earnings	-18.56
EV / Sales	1.15
EV / EBITDA	21.19
EV / EBIT	44.79
EV / FCF	15.03

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.51.

Current Ratio	1.30
Quick Ratio	0.69
Debt / Equity	0.51
Debt / EBITDA	3.92
Debt / FCF	2.78
Interest Coverage	1.59

Financial Efficiency

Return on equity (ROE) is -14.06% and return on invested capital (ROIC) is 2.35%.

Return on Equity (ROE)	-14.06%
Return on Assets (ROA)	1.62%
Return on Invested Capital (ROIC)	2.35%
Return on Capital Employed (ROCE)	4.22%
Revenue Per Employee	12.47M
Profits Per Employee	-770,905
Employee Count	42
Asset Turnover	1.01
Inventory Turnover	3.13

Taxes

In the past 12 months, Navamedic ASA has paid 3.93 million in taxes.

Income Tax	3.93M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.18% in the last 52 weeks. The beta is 0.31, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-27.18%
50-Day Moving Average	21.98
200-Day Moving Average	22.24
Relative Strength Index (RSI)	55.37
Average Volume (20 Days)	265,061

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 523.56 million and -32.38 million in losses. Loss per share was -1.85.

Revenue	523.56M
Gross Profit	191.55M
Operating Income	13.42M
Pretax Income	-28.45M
Net Income	-32.38M
EBITDA	25.27M
EBIT	13.42M
Loss Per Share	-1.85

Balance Sheet

The company has 42.66 million in cash and 111.26 million in debt, giving a net cash position of -68.60 million or -2.86 per share.

Cash & Cash Equivalents	42.66M
Total Debt	111.26M
Net Cash	-68.60M
Net Cash Per Share	-2.86
Equity (Book Value)	216.55M
Book Value Per Share	12.26
Working Capital	50.72M

Cash Flow

In the last 12 months, operating cash flow was 43.40 million and capital expenditures -3.41 million, giving a free cash flow of 39.98 million.

Operating Cash Flow	43.40M
Capital Expenditures	-3.41M
Free Cash Flow	39.98M
FCF Per Share	1.67

Margins

Gross margin is 36.59%, with operating and profit margins of 2.56% and -6.18%.

Gross Margin	36.59%
Operating Margin	2.56%
Pretax Margin	-5.43%
Profit Margin	-6.18%
EBITDA Margin	4.83%
EBIT Margin	2.56%
FCF Margin	7.64%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-6.08%
FCF Yield	7.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Navamedic ASA has an Altman Z-Score of 2.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.32
Piotroski F-Score	4